Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adagrasib Rollover Study in Solid Tumors
NCT07415031Phase 2Recruiting
- Sponsor
- Mirati Therapeutics
- Start
- May 2026
- Primary completion
- Feb 2028
- Countries
- 21
01
Overview
A Phase 2 trial of adagrasib in solid tumor, sponsored by Mirati Therapeutics. Started May 2026; status: recruiting.
02
Drugs
adagrasib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07415031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07415031.